Biomedical Engineering Reference
In-Depth Information
89. Kogure, K., R. Moriguchi, K. Sasaki, M. Ueno, S. Futaki, and H. Harashima
(2004). Development of a non-viral multifunctional envelope-type
nano device by a novel lipid film hydration method,
J Control Release
98
: pp. 317-323.
90. Koltover, I., T. Salditt, J.O. Radler, and C.R. Safinya (1998). An inverted
hexagonal phase of cationic liposome-DNA complexes related to DNA
release and delivery,
Science (Washington, D. C.)
281
: pp. 78-81.
91. Kumar, P., H.S. Ban, S.S. Kim, H. Wu, T. Pearson, D.L. Greiner, A. Laouar,
J. Yao, V. Haridas, K. Habiro, Y.G. Yang, J.H. Jeong, K.Y. Lee, Y.H. Kim,
S.W. Kim, M. Peipp, G.H. Fey, N. Manjunath, L.D. Shultz, S.K. Lee, and
P. Shankar (2008). T cell-specific siRNA delivery suppresses HIV-1
infection in humanized mice,
Cell
.
134
: pp. 577-586.
92. Kumar, P., H. Wu, J.L. McBride, K.E. Jung, M.H. Kim, B.L. Davidson, S.K.
Lee, P. Shankar, and N. Manjunath (2007). Transvascular delivery of
small interfering RNA to the central nervous system,
Nature
.
448
: pp.
39-43.
93. Kwon, E.J., J.M. Bergen, and S.H. Pun (2008). Application of an HIV gp41-
derived peptide for enhanced intracellular trafficking of synthetic gene
and siRNA delivery vehicles,
Bioconjugate Chem.
19
: pp. 920-927.
94. Lagos-Quintana, M., R. Rauhut, W. Lendeckel, and T. Tuschl (2001).
Identification of novel genes coding for small expressed RNAs,
Science
.
294
: pp. 853-858.
95. Latchman, Y., C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, I.
Chernova, Y. Iwai, A.J. Long, J.A. Brown, R. Nunes, E.A. Greenfield, K.
Bourque, V.A. Boussiotis, L.L. Carter, B.M. Carreno, N. Malenkovich, H.
Nishimura, T. Okazaki, T. Honjo, A.H. Sharpe, and G.J. Freeman (2001).
PD-L2 is a second ligand for PD-1 and inhibits T cell activation,
Nat
Immunol
.
2
: pp. 261-268.
96. Leachman, S.A., R.P. Hickerson, P.R. Hull, F.J. Smith, L.M. Milstone,
E.B. Lane, S.J. Bale, D.R. Roop, W.H. McLean, and R.L. Kaspar (2008).
Therapeutic siRNAs for dominant genetic skin disorders including
pachyonychia congenita,
J Dermatol Sci
.
51
: pp. 151-157.
97. Leachman, S.A., R.P. Hickerson, M.E. Schwartz, E.E. Bullough, S.L.
Hutcherson, K.M. Boucher, C.D. Hansen, M.J. Eliason, G.S. Srivatsa,
D.J. Kornbrust, F.J. Smith, W.I. McLean, L.M. Milstone, and R.L. Kaspar
(2009). First-in-human mutation-targeted siRNA phase Ib trial of an
inherited skin disorder,
Mol Ther
.
18
: pp. 442-446.
98. Lee, S.K., D.M. Dykxhoorn, P. Kumar, S. Ranjbar, E. Song, L.E. Maliszewski,
V. Francois-Bongarcon, A. Goldfeld, N.M. Swamy, J. Lieberman, and P.
Shankar (2005). Lentiviral delivery of short hairpin RNAs protects
CD4 T cells from multiple clades and primary isolates of HIV,
Blood
.
106
: pp. 818-826.
Search WWH ::
Custom Search